Jan 31, 2018
By Michelle Saunders
Yesterday Canada’s generic drug industry agreed to cut prices 25% to 40 % for Provincial/Public drug plans. They made this promise in exchange for suspending open tenders for five years. It’s obviously good news for taxpayers, but will it have a direct effect on you? Will it bring down the cost of drugs not covered by the agreement and for people who are not covered by public plans and for employers for that matter. We spoke to the country’s foremost expert of drug plans Dr. Steve Morgan at UBC.